|
![blank](/z.gif) |
Àâòîðèçàöèÿ |
|
![blank](/z.gif) |
Ïîèñê ïî óêàçàòåëÿì |
|
![blank](/z.gif) |
|
![blank](/z.gif) |
|
![blank](/z.gif) |
![Êðàñîòà](/img/main/17.jpg) |
|
![blank](/z.gif) |
|
Lydyard P.M., Whelan A., Fanger M.W. — Instant Notes in Immunology |
|
![blank](/z.gif) |
Ïðåäìåòíûé óêàçàòåëü |
-1 anti chymotrypsin 29
-1 anti trypsin 29
-2-microglobulin 104—106
-hemolytic Streptococcus 116
a-melanocyte-stimulating hormone 112
ABO blood groups 199 203 246
Accessory molecules 87
Acetylcholine receptor 244 246 260 269 288
Acid hydrolases 242
Acquired immunodeficiency 223—224 229—231
Active Immunization 214—216
Acute inflammation 5 109—112
Acute inflammatory response 109—112
Acute inflammatory response, initiation of the acute inflammatory response 109—110
Acute inflammatory response, termination of the response and repair 111—112
Acute inflammatory response, vascular changes 110—111
Acute phase proteins 23 28—29
Acute phase proteins, function 29
Acute phase proteins, production 28—29
Adaptive immune system 5—7 33—48
Adaptive immune system, B lymphocytes and plasma cells 26 33 35—37 115—122
Adaptive immune system, bone marrow 38—39
Adaptive immune system, bronchus-associated lymphoid tissue 43 45
Adaptive immune system, gut-associated lymphoid tissue 43—45
Adaptive immune system, lymph nodes 38—39 41—42
Adaptive immune system, lymphocyte traffic and recirculation 46—48
Adaptive immune system, mechanisms of lymphocyte trafficking 46—48
Adaptive immune system, mucosa-associated lymphoid tissue 43—45
Adaptive immune system, nasal-associated lymphoid tissue 43—44
Adaptive immune system, primary lymphoid organs 38—39
Adaptive immune system, secondary lymphoid organs 38 40—45
Adaptive immune system, specificity and memory 33—34
Adaptive immune system, spleen 38 40—41
Adaptive immune system, T lymphocytes 33—36
Adaptive immunity 5—7 33—48
ADCC 47 190—192
Addressins 29 98
Adenosine deaminase 227
Adenovirus 222
Adhesion molecules 48
Adipocytes 50
Adjuvants 217 219
Afferent lymphatics 41—42
Affinity 63 65 117
Affinity chromatography 283
Affinity maturation 117—118
Ageing 229—231
Agglutination assays 276—278
AIDS 229—231
Alleles 199—201
Allelic exclusion 70 74
Allergens 18—19 241—2143
Allergic rhinitis 241
Allergy 237—243
Alloantigens 200—201
Allografts 197 202—203
Allotypes 78
Alpha-fetoprotein 180—181
Alternative complement pathway 24—27
Alveolar macrophages 14
Alveolitis 249
Amebiasis 173
Anaerobes 4
Anamnestic responses 115
Anaphylatoxins 26
Anaphylaxis 239 241—242
Anergy 149—151
Anti-double stranded DNA 260—272
Anti-inflammatory cytokines 109 112
Anti-nuclear antibodies 257 261 272
Antibodies 63—84
Antibodies as research and diagnostic tools 275—286
Antibodies as research and diagnostic tools, complement activation 80—82
Antibodies as research and diagnostic tools, Coomb's test 273—278
Antibodies as research and diagnostic tools, ELISA 279—280
Antibodies as research and diagnostic tools, ELISPOT 279 282
Antibodies as research and diagnostic tools, immunodiffusion 276—277
Antibodies as research and diagnostic tools, immunoelectrophoresis 276—277
Antibodies as research and diagnostic tools, immunofluorescence 279—282
Antibodies as research and diagnostic tools, neutralization 65 80 275
Antibodies as research and diagnostic tools, precipitation assays 276—277
Antibodies as research and diagnostic tools, radial-immuno-diffusion 276—277
Antibodies as research and diagnostic tools, rocket immunoelectrophoresis 276
Antibodies in the newborn 60—61 64 244—246
Antibodies, affinity 63 65 114
Antibodies, allelic exclusion 70 74
Antibodies, allotypes 78
Antibodies, antibody functions 80—82
Antibodies, antibody genes 70—72
Antibodies, antigen selection for B cells 71 77
Antibodies, antigenic determinant 9—11 65
Antibodies, avidity 65—66
Antibodies, classes 64 67—69
Antibodies, classes, IgA 67—69 119—120
Antibodies, classes, IgD 67 69
Antibodies, classes, IgE 67 68
Antibodies, classes, IgG 67 68
Antibodies, classes, IgM 67 69
Antibodies, differential splicing and class switching 41—70 70—76 117—118
Antibodies, diversity 70—77
Antibodies, Fab fragments 64
Antibodies, Fc fragment 64—65
Antibodies, Fv libraries 83—84
Antibodies, gene rearrangement 70 72—73
Antibodies, generation of diversity 70—77
Antibodies, genes 70—72
Antibodies, H and L chains 63—69
Antibodies, hydrophilic interactions 63
Antibodies, hydrophobic interactions 63
Antibodies, idiotypes 78—79 164—165 266—267
Antibodies, monoclonal antibodies 33 284—285
Antibodies, primary response 7—8 113—115
Antibodies, role of antibody in complement activation 80—81
Antibodies, role of antibody with effector cells 80 82
Antibodies, synthesis and assembly of chains 70 74—75
Antibodies, valence 63 65—66
Antibodies, ways of creating diversity 71 76—77
Antibody mediated protection 80—82
Antibody responses 113—122
Antibody responses in different tissues 119—120
Antibody responses, affinity maturation 77 117—118
Antibody responses, class switching 70 75—76 117—118
Antibody responses, cross-reactive responses 113 115—116
Antibody responses, immunological memory 113—115
Antibody responses, primary and memory responses 113—115
Antibody responses, selection and activation of B cells 113—115
Antibody responses, the cellular basis of 113—116
Antigen preparations used in vaccines 217—219
Antigen presenting cells (APCs) 97 100 103 108
Antigen processing 104—108
Antigen processing, endogenous pathway 104 107—108
Antigen processing, exogenous pathway 104 107—108
Antigen recognition 95—108
Antigen recognition, antigen processing by the major histocompatibility complex 104—108
Antigen recognition, B cell co-receptors 98—99
Antigen recognition, B cell receptor complex 98
Antigen recognition, B cell recognition of antigen 98—99
Antigen recognition, CD14 95 97
Antigen recognition, mannose receptor 95—97
Antigen recognition, non-self recognition by the innate immune system 95—97
Antigen recognition, pattern recognition receptors 95—96
Antigen recognition, scavenger receptors 95 97
Antigen recognition, T cell diversity 100 102—103
Antigen recognition, T cell receptor 100—102
Antigen recognition, T cell receptor complex 100 102
Antigen recognition, T cell recognition of antigen 100—103
Antigen recognition, T cell repetoire 100 103
Antigen recognition, toll receptors 95 97
Antigens 9—11
Antigens, antigenic determinants 8—11 65
| Antigens, carbohydrates 9
Antigens, epitopes 9
Antigens, haptens 10—11
Antigens, linear ammo acid sequences 9
Antigens, lipids 9
Antigens, multi-determinant 9
Antigens, native 10
Antigens, not 'self 9
Antigens, nucleic acids 9
Antigens, range of antigens 6—9
Antigens, structure 9—11
Apoptosis 52 54 56 124 126—128 167 169 183 184 189 191
Appendix 119
Arabinomannans 96—97
Arthus reaction 248—249
Autoantibodies 268—271
Autoantigens 257 259—260
Autografts 197
Autoimmune haemolytic anaemia 265 268—270
Autoimmune thyroiditis 255 260 270
Autoimmunity and autoimmune diseases 255—274
Autoimmunity and autoimmune diseases, autoantibodies can modulate cell function 268—269
Autoimmunity and autoimmune diseases, autoantibody mediated destruction 268—269
Autoimmunity and autoimmune diseases, breakdown of tolerance 262—263
Autoimmunity and autoimmune diseases, cell mediated immune mechanisms of damage 268 271
Autoimmunity and autoimmune diseases, defective regulation of Th1, Th2 262 265
Autoimmunity and autoimmune diseases, diagnosis 272—273
Autoimmunity and autoimmune diseases, diagnosis and treatment 272—274
Autoimmunity and autoimmune diseases, disease pathogenesis -effector mechanisms 268—271
Autoimmunity and autoimmune diseases, drugs and autoimmune reactions 257 261
Autoimmunity and autoimmune diseases, dysregulation of the idiotypic network 263 266
Autoimmunity and autoimmune diseases, factors contributing to the development 257—261
Autoimmunity and autoimmune diseases, immune complexes 268 270—271
Autoimmunity and autoimmune diseases, immunodeficiency 258 261
Autoimmunity and autoimmune diseases, mechanisms leading to the development 262—267
Autoimmunity and autoimmune diseases, modification of cell surfaces 262 265—266
Autoimmunity and autoimmune diseases, molecular mimicry 262—264
Autoimmunity and autoimmune diseases, polyclonal activation 262 265
Autoimmunity and autoimmune diseases, prevalence 255—256
Autoimmunity and autoimmune diseases, replacement therapy 272—273
Autoimmunity and autoimmune diseases, sequestered self antigens 263 266
Autoimmunity and autoimmune diseases, spectrum of autoimmune conditions 255—256
Autoimmunity and autoimmune diseases, suppression of the autoimmune process 272—274
Autoimmunity and autoimmune diseases, tissue damage 268—269
Avidity 45—46
Avirulent 116
Azathioprine 273
B cell activation 138—142
B cell activation, biochemical events 138 141—142
B cell activation, thymus dependent antigens 138—141
B cell activation, thymus independent antigens 138—139
B cell co-receptors 98—99
B cell follicles 36
B cell receptor complex (BCR) 98—99
B cell recognition of antigen 98—99
B cell tolerance 147 154
B cells 6—8 10 55—59 104—108 113—115 117—118
B-7 149—151 195
B1 cells 35
B2 cells 35
B7.1 (CD80) 149—151 195
B7.2 (CD86) 149—151 195
Bacterial toxins 96 97 110
Bacterial vaccines 221—222
Bacteriophage 286
Basophils 18 19 109 110 240—243
BCG 188
Bee venom 239
Bird fancier's disease 248—249
Blood group antigens 166 203 246
Bone marrow 35 38 39 46 49—51 53 55 56 80—82 229 231—235
Bordetella pertussis 216
Borrelia burgdorferi 259
Borrelia recurrentis 177
Botulism 215
Bradykinin system 109 242
Bronchus-associated lymphocyte tissue (BALT) 43 45
Brucella 170—171 176
Bruton's agammablobulinaemia 142 225 227
Burkitts Lymphoma 179
Burnet 194
Burns 229 231
Bursa of Fabricius 56
C parvum 188
C-reactive protein (CRP) 28—29
C1q 81
C1q inhibitor 27 226
C3a 24—26 181—182
C3b 24—26 81—82
C4a 81
C5a 25—26 81—82
C9 24—26 81
CA-125 185—186
CA-19-9 185—186
Candida 1 233
Carcinoembryonic antigen 180—181 186—187
Cationic protein 168—173
CC chemokines 87 90—91
CD14 95—97
CD19 55 98—99
CD21 98—99
CD28 150 151
CD3 34 35
CD32 98—99
CD4 20 33 102—103
CD40 37 117—118 130 225 227 230 232
CD40 ligand (CD40L) 36 117—118 130 225 227 232 274
CD79a, CD79b 98—99
CD8 33 35 103
CD81 98—99
Cecropins 3
Cell mediated immunity 123—130
Cell mediated immunity, cell mediated immunity in context 123—124
Cell mediated immunity, functionally distinct T cell populations 123—124
Cell mediated immunity, mechanisms of toxicity 126—128
Cell mediated immunity, peptide recognition and activation of 126
Cell mediated immunity, T cell mediated immunity 123
Cell mediated immunity, T cytotoxic cells 126—128
Cell mediated immunity, T helper cells 129—130
Cell mediated immunity, Th1 cells and Th2 cells 129—130
Cellular adhesion molecules 48
Cellular immunity 123—130
Central Tolerance 147—148
Cerumen 3
CH50 233
Chediak — Higashi syndrome 226
Chemokine receptors 230
Chemokines 85 90—91
Chemotaxis 80—82 233 234
Chimeric 284 286
Cholera 212 216 218
Chronic granulomatous disease (CGD) 225—227
Cilia 3
Class I genes (HLA-A, -B, -C) 104—105
Class I processing pathways 104 107
Class II genes 104—106
Class II processing pathways 104 107—108
Classical pathway of complement 80—82
Clonal deletion 144 147 149
Clonal expansion 7 114
Clonal selection 5 7—8 113—115
Clostridium 212 214
Coeliac disease 257 259—260
Colicins 3
Collagen 109 112
Collectins 32
Colony stimulating factors 87 91—92
Colostrum 60 61 68
Commensals 2 3 4
Common variable immunodeficiency (CVID) 225 227
|
|
![blank](/z.gif) |
Ðåêëàìà |
![blank](/z.gif) |
|
|